Skip to main content
Log in

Influence of cysteine proteinase inhibitors on platelet and plasma components of blood coagulation system

  • Published:
Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology Aims and scope

Abstract

Factor XIIIa plays an important role in stabilization of formed fibrin clot during blood coagulation. Recent studies proved that factor XIIIa affects formation of coated platelets, which are highly procoagulant and characterized by a high level of alpha-granular proteins on their surface and expose surface phosphatidylserine after platelet activation. The ability of newly found cysteine proteinase inhibitors (CPIs) from plants to affect thiol group of the factor XIIIa active centre was recently discovered. Here, the effect of CPIs on the formation of coated platelets and activity of plasma components during blood coagulation process was investigated. It was found that CPIs dose-dependently decreased the fraction of coated platelets in the total platelet population during platelet activation and decreased endogenous thrombin potential (ETP) by 40% for thrombin generation in platelet-rich as well as in platelet-poor plasma. Such decrease of ETP could not be explained by the CPIs influence on factor XIIIa. Investigation of the effects of these inhibitors on factor Xa and thrombin activity has shown that CPIs dose-dependently inhibited their activity and might cause an ETP decrease. Thus, the obtained data indicated that CPIs affected both platelet and plasma components of blood coagulation system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Refernces

  1. Zwaal, R.F.A. and Schroit, A.J., Pathophysiologic Implications of Membrane Phospholipids Asymmetry in Blood Cells, Blood, 1997, vol. 89, no. 4, pp. 1121–1132.

    CAS  PubMed  Google Scholar 

  2. Alberio, L., Safa, O., Clemetson, K.J., Esmon, C.T., and Dale, G.L., Surface Expression and Functional Characterization of α-Granule Factor V in Human Platelets: Effect of Ionophore A23187, Thrombin, Collagen, and Convulxin, Blood, 2000, vol. 95, pp. 1694–1702.

    CAS  PubMed  Google Scholar 

  3. Dale, G.L., Friese, P., Batar, P., Hamilton, S.F., Reed, G.L., Jackson, K.W., Clemetson, K.J., and Alberio, L., Stimulated Platelets Use Serotonin to Enhance Their Retention of Procoagulant Proteins on the Cell Surface, Nature, 2002, vol. 415, pp. 175–179.

    Article  CAS  PubMed  Google Scholar 

  4. Sane, D.C., Kontos, J.L., and Greenberg, C.S., Roles of Transglutaminases in Cardiac and Vascular Diseases, Bioscience, 2007, vol. 12, pp. 2530–2545.

    CAS  Google Scholar 

  5. Serrano, K., and Devine, D.V., Intracellular Factor XIII Cross Links Platelet Cytoskeletal Elements upon Platelet Activation, Thromb. Haemost., 2002, vol. 88, pp. 315–320.

    CAS  PubMed  Google Scholar 

  6. Greenberg, C.S., Birckbichler, P.J., and Rice, R.H., Transglutaminases: Multifunctional Cross-Linking Enzymes that Stabilize Tissues, FASEB J., 1991, vol. 5, pp. 3071–3077.

    CAS  PubMed  Google Scholar 

  7. Kostanova, E.A., Rosenfel’d, M.A., Revina, T.A., and Valueva, T.A., Protein Inhibitors of Fibrin-Stabilizing Factor XIII, Izvestiya Academii Nauk (Rus.), 2007, vol. 3, pp. 347–353.

    Google Scholar 

  8. Sugimura, Y., Hosono, M., Wada, F., Yoshimura, T., Maki, M., and Hitomi, K., Screening for the Preferred Substrate Sequence of Transglutaminase Using a Phage-Displayed Peptide Library. Identification of Peptide Substrates for TGase2 and Factor XIIIa, J. Biol. Chem. 2006, vol. 281, no. 26, pp. 17 699–17 706.

    Article  CAS  Google Scholar 

  9. Lewis, S.D., Janus, T.J., Lorand, L., and Shafer, J.A., Regulation of Formation of Factor XIIIa by its Fibrin Substrates, Biochemistry, 1985, vol. 24, pp. 6772–6777.

    Article  CAS  PubMed  Google Scholar 

  10. Arnon, R. and Shapira, E., Antibodies to Papain. A Selective Fractionation According to Inhibitory Capacity, Biochemistry, 1967, vol. 6, no. 12, pp. 3942–3950.

    Article  CAS  PubMed  Google Scholar 

  11. Davieva, D.T. and Law, A.J., An Improved Method for the Quantitative Fraction of Casein Mixtures Using Ion-Exchange Chromatography, J. Dairy Res., 1977, vol. 44, pp. 213–221.

    Article  Google Scholar 

  12. Laemmli, U.K., Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4, Nature, 1970, vol. 227, no. 5259, pp. 680–685.

    Article  CAS  PubMed  Google Scholar 

  13. Cooke, R.D., and Holbrook, J.J., Calcium and the Assay of Human Plasma Clotting Factor XIII, Biochem. J., 1974, vol. 141, pp. 71–78.

    CAS  PubMed  Google Scholar 

  14. Israels, E.D., Paraskevas, F., and Israels, L.G., Immunological Studies of Coagulation Factor XIII, J. Clin. Invest., 1973, vol. 52, no. 10, pp. 2398–2403.

    Article  CAS  PubMed  Google Scholar 

  15. Lorand, L., Parameswaran, K.N., Velasco, P.T., Hsu, L.K., and Siefring, G.E. Jr., New Colored and Fluorescent Amine Substrates for Activated Fibrin Stabilizing Factor (Factor XIIIa) and for Transglutaminase, Anal. Biochem., 1983, vol. 131, no. 2, pp. 419–425.

    Article  CAS  PubMed  Google Scholar 

  16. Gorman, J.J. and Folk, J.E., Structural Features of Glutamine Substrates for Human Plasma Factor XIIIa (Activated Blood Coagulation Factor XIII), J. Biol. Chem., 1980, vol. 255, no. 2, pp. 419–427.

    CAS  PubMed  Google Scholar 

  17. Hemker, H.C., Giesen, P.L.A., Ramjee, M., Wagenvoord, R., and Beguin, S., The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma, Thromb. Haemost., 2000, vol. 83, no. 4, pp. 589–591.

    CAS  PubMed  Google Scholar 

  18. Hemker, H.C., Giesen, P.L.A., AlDieri, R., Regnault, V., de Smed, E., Wagenvoord, R., Lecompte, T., and Beguin, S., The Calibrated Automated Thrombogram (CAT): A Universal Routine Test for Hyper- and Hypocoagulability, Pathophysiol. Haemost. Thromb., 2002, vol. 32, nos. 5–6, pp. 249–253.

    Article  CAS  PubMed  Google Scholar 

  19. Jobe, S.M., Leo, L., Eastvold, J.S., Dickeneite, G., Ratliff, T.L., Lentz, S.R., and Paola, J.D., Role of FcRg and Factor XIIIA in Coated Platelet Formation, Blood, 2005, vol. 106, pp. 4146–4151.

    Article  CAS  PubMed  Google Scholar 

  20. Kohler, H.-P., Role of Blood Coagulation Factor XIII in Vascular Disease, Swiss Med. Wkly, 2001, vol. 131, pp. 31–34.

    CAS  PubMed  Google Scholar 

  21. Ametov, A.S. and Kondrat’eva, L.V., Metaformin, Basic of Therapy Patient with Metabolic Syndrome, Endokrinologiya (Rus.), 2006, vol. 14, no. 26, pp. 1905–1911.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ya. N. Kotova.

Additional information

Original Russian Text © Ya.N. Kotova, E.A. Kostanova, M.A. Rozenfel’d, E.I. Sinauridze, M.A. Panteleev, F.I. Ataullakhanov, 2009, published in Biologicheskie Membrany, 2009, Vol. 26, No. 6, pp. 514–520.

The article was translated by the authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kotova, Y.N., Kostanova, E.A., Rozenfel’d, M.A. et al. Influence of cysteine proteinase inhibitors on platelet and plasma components of blood coagulation system. Biochem. Moscow Suppl. Ser. A 3, 447–452 (2009). https://doi.org/10.1134/S1990747809040126

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990747809040126

Key words

Navigation